Related Experiment Video
Updated: Dec 25, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay
Shuying Cai1,2, Jinliang Li1, Ye Wu1
1Department of Pediatrics, Peking University First Hospital, Peking, 100034, China.
Insights
De novo variants in TUBB2A gene are associated with infantile-onset epilepsy and global developmental delay. These TUBB2A mutations often lead to brain malformations like cortical and corpus callosum dysplasia.
Area of Science:
- Neurogenetics
- Developmental Neuroscience
- Epileptology
Background:
- TUBB2A gene mutations are increasingly recognized as a cause of neurodevelopmental disorders.
- Infantile-onset epilepsy and global developmental delay are significant clinical manifestations.
Observation:
- Two new cases of infantile-onset epilepsy with global developmental delay due to de novo TUBB2A variants are presented.
- Literature review identified a total of nine patients with TUBB2A mutations, exhibiting a spectrum of neurological and neuroimaging findings.
- Common findings include developmental delay, epilepsy, cortical dysplasia, and corpus callosum abnormalities.
Findings:
- De novo variants in TUBB2A are linked to infantile-onset epilepsy and global developmental delay.
- Brain MRI often reveals cortical dysplasia and corpus callosum abnormalities.
- The p.A248V mutation is the most frequent, with consistent phenotypes including global developmental delay and corpus callosum dysplasia.
Implications:
- The study highlights TUBB2A as a crucial gene in early neurodevelopment.
- Understanding TUBB2A mutation hotspots may aid in diagnosing and managing related neurodevelopmental disorders.
- Further research into genotype-phenotype correlations can refine diagnostic and therapeutic strategies.
Abstract:
We analyzed our two new cases of infantile-onset epilepsy with developmental delay with de novo variant in TUBB2A and review the related literatures. Our two probands were both girls with infantile-onset epilepsy and global developmental delay. Case 1 had a novel de novo heterozygous missense variant: c.728C>T [p.Pro243Leu] (NM_001069.2). Her brain magnetic resonance imaging (MRI) showed nonspecific white matter myelination delay and slightly enlarged anterior horn of lateral ventricle. Her epilepsy had been controlled by TPM monotherapy. Case 2 had a reported de novo variant c.743C>T [p.Ala248Val] (NM_001069.2). Her brain MRI showed bilateral microgyria and corpus callosum dysplasia. A total of seven TUBB2A mutations cases had been published previously in five papers, therefore, until now, there were nine patients with TUBB2A mutations. All patients had developmental delay, among them seven cases also with infantile-onset epilepsy, one case with abnormal EEG but without clinical seizures. There are six cases that have different degree of cortical dysplasia, one case with cerebellar vermis atrophy and brainstem sacsinopathy, the rest two cases have no obvious brain structural abnormalities. There was one case with variant c.1249G>A (p.D417N) that had atypical clinical presentation, including prominent progressive spastic ataxia, sensory motor axonal neuropathy, and bilateral optic macular dystrophy, but relatively mild intellectual disability, his MRI showed cerebellar atrophy, thinning of the corpus callosum and pons sacsinopathy, but no cortical malformation. The p.A248V mutation was the most common mutation occurred in three patients (3/9). The clinical phenotypes of these three patients were similar, all of them had global developmental delay with no language and corpus callosum dysplasia, two cases with epilepsy and the other one only have EEG epileptic discharges without clinical seizure, two cases with cortical dysplasia and the other one without obvious brain malformation. In brief, global developmental delay was the most common phenotype of TUBB2A mutation-related disease, most cases also had infantile-onset epilepsy and cortical dysplasia and corpus callosum dysplasia. The region between seventh and eighth alpha-helix of TUBB2A may be a "hot spot" mutation domain.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Microtubule Instability
Inborn Errors of Metabolism
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Teratogenicity
Destabilization of Microtubules